Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
10 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Cancidas (previously Caspofungin MSD)“
Suchtreffer
Begriffe & Kennungen
Cancidas (previously Caspofungin MSD) · 4.8 · Caspofungin has also been evaluated at 150 mg daily (for up to 51 days) in 100 adult patients (see section 5.1
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · Hypersensitivity reactions (anaphylaxis and possibly histamine-mediated adverse reactions) have been reported
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · Phlebitis was a commonly reported local injection-site adverse reaction in all patient populations. Other loca
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · Reported clinical and laboratory abnormalities among all adults treated with caspofungin (total 1,780) were ty
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · System Organ Class Very Common (≥1/100 to <1/10) common (≥1/10) Blood and lymphatic system eosinophil count in
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · System Organ Common (≥1/100 to Uncommon (≥1/1,000 to <1/100) Not known Class <1/10) (cannot be estimated from
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · The following adverse reactions were reported during clinical studies and/or post-marketing use:
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · The following adverse reactions were reported:
Eintrag öffnen